Results 191 to 200 of about 95,506 (252)

An engineered intradermal microneedle-array device enhances the cellular immune responses in a guinea pig model. [PDF]

open access: yesFront Immunol
Nepveu-Traversy ME   +7 more
europepmc   +1 more source

Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine. [PDF]

open access: yesHum Vaccin Immunother
Ma C   +8 more
europepmc   +1 more source

Estimating Enteric Fever Seroincidence in Bangladesh Using Rapid Serosurveys. [PDF]

open access: yesOpen Forum Infect Dis
Munira SJ   +15 more
europepmc   +1 more source

Marker Test of Poliovirus in Relation to Mass Vaccination with Live Oral Vaccines

open access: yesMarker Test of Poliovirus in Relation to Mass Vaccination with Live Oral Vaccines
openaire  

Marker vaccine strategies and candidate CSFV marker vaccines

Vaccine, 2007
Classical swine fever (CSF) is an economically important highly contagious disease of swine worldwide. Classical swine fever virus (CSFV) is its etiological agent, and the only natural hosts are domestic pigs and wild boars. Although field CSFV strains vary in the virulence, they all result in serious losses in pig industry.
Ying-Hua Chen, Xiao-Nan Dong
exaly   +3 more sources

The use of marker vaccines in eradication of herpesviruses

Journal of Biotechnology, 1996
Marker vaccines are vaccines that allow serological differentiation between infected and vaccinated individuals. This differentiation is based on the absence of one or more microbial proteins in the vaccine that are present in the wild-type micro-organism.
van Oirschot, J.T.   +3 more
openaire   +4 more sources

Predictive markers of safety and immunogenicity of adjuvanted vaccines

Biologicals, 2013
Vaccination represents one of the greatest public health triumphs; in part due to the effect of adjuvants that have been included in vaccine preparations to boost the immune responses through different mechanisms. Although a variety of novel adjuvants have been under development, only a limited number have been approved by regulatory authorities for ...
Mastelic B   +6 more
openaire   +3 more sources

An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines

Veterinary Microbiology, 1996
A comparative study on the efficacy of 3 bovine herpesvirus 1 (BHV1) marker vaccines was carried out. An attenuated gE-negative vaccine, an inactivated gE-negative vaccine and an experimental gD-subunit vaccine were tested twice in a vaccination-challenge experiment in cattle.
Bosch, J.C.   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy